Cellular Therapies for Retinal Disease

Cellular Therapies for Retinal Disease

Author: Steven D. Schwartz

Publisher: Springer

Published: 2017-06-20

Total Pages: 149

ISBN-13: 3319494791

DOWNLOAD EBOOK

This book familiarizes the reader with the current landscape of cell-based therapies for the treatment of retinal disease, including diseases that affect the choriocapillaris, retinal pigment epithelium, photoreceptors, and retinal ganglion cells. Instead of utilizing a disease-centric approach to the topic, this book—edited by two world-renowned stem cell scientists—focuses on strategies for developing and transplanting the cells. This includes the creation of replacement cells, cell-based neuroprotection, and in vitro disease modeling and testing. The final chapters briefly review parallel approaches that do not directly utilize cellular transplantation. The use of cellular transplantation to treat retinal disease has recently become a viable and exciting therapeutic approach. The visibility of the retina and its laminar cellular architecture render it an ideal organ for the development of surgically delivered cellular therapies. Having an in-depth understanding of the current state of cell therapy for the eye is an essential first step toward utilizing similar approaches in other organs. Ophthalmologists, translational clinician-scientists, stem cell scientists, and researchers interested in eye disease will find Cellular Therapies for Retinal Disease: A Strategic Approach essential reading and it is also suitable for workshops or courses at the undergraduate or Ph.D. level.


Towards an in Vitro Model for Age-related Macular Degeneration

Towards an in Vitro Model for Age-related Macular Degeneration

Author: Lena Mesch

Publisher:

Published: 2021

Total Pages: 0

ISBN-13:

DOWNLOAD EBOOK

The human retina is a complex tissue within the human eye and essential for the sense of sight. Retinal diseases, such as age-related macular degeneration (AMD) or retinitis pigmentosa (RP) affect or destroy the sense of vision and impair the quality of life of patients drastically. As currently for many retinal diseases there are only few, or no treatment options available and animal models recapitulate the pathology of those diseases poorly. Therefore, adequate in vitro models of the human retina and the supporting retinal pigment epithelium (RPE) are urgently required. In AMD, pathological changes do not exclusively involve cells of the neural retina, but initial disease manifestation takes place within the retinal pigment epithelium (RPE) and its near surroundings. Therefore, various protocols for the differentiation of RPE cells from human pluripotent stem cells (hPSCs) have been developed in recent years, showing the generation of mature and functional RPE cells. In this thesis, two distinct approaches for the differentiation of hiPSC-RPE have been applied and were subsequently investigated for several essential characteristics of RPE cells. These essential RPE hallmarks included molecular characteristics, pigmentation, and morphology. Overall analysis demonstrated that both approaches equivalently generated RPE cells of good quality. Nevertheless, RPE cells which are cultured on plastic surfaces in 2D pose several disadvantages, as those conditions promote e.g. transdifferentiation or detachment from the culture plate. Consequently, long-term cultivation over several month to years remains difficult. In this thesis, those drawbacks were aimed to overcome by implementing a novel three-dimensional RPE organoid (RPEorg) approach. RPE organoids were differentiated simultaneously with retinal organoids and cultured for more than 300 days. A basic characterization of early (day 80-100), intermediate (day 191) and aged (day 280-360) RPEorg was performed by immunostainings and qRT-PCR analysis. RPEorg expressed several common RPE markers, some of them strongly increasing with age. Deeper analyses of RPEorg showed ultrastructural signs of mature RPE cells, such as apical microvilli and tight junctions, as well as melanosomes. Functionality of RPE cells comprised in RPEorg was demonstrated by phagocytosis of bovine photoreceptor outer segments (POS). Overall, maturation of RPE cells with age could be observed. As a next step, RPE organoids were investigated for age-related changes in the context for AMD. Therefore, RPEorg were stained for drusen-associated proteins, such as APOE and TIMP3, lipids and hydroxyapatite. Those data were supported by qRT-PCR analysis and showed presence and partly upregulation of several disease relevant markers with aging. Additionally, transmission electron microscopy revealed ultrastructural signs of drusen formation in aged RPEorg. To summarize, RPEorg are a suitable model for mature RPE and allows for investigations of age-associated changes related to AMD. Long-term cultivation of RPEorg enables studies of early stages of disease manifestation and drusen formation, which renders it suitable for pathomechanistic as well as drug developmental studies.


Human Embryonic Stem Cells

Human Embryonic Stem Cells

Author: Jon Odorico

Publisher: Garland Science

Published: 2004-02-01

Total Pages: 391

ISBN-13: 0203487346

DOWNLOAD EBOOK

Since the first successful isolation and cultivation of human embryonic stem cells at the University of Wisconsin, Madison in 1998, there has been high levels of both interest and controversy in this area of research. This book provides a concise overview of an exciting field, covering the characteristics of both human embryonic stem cells and pluripotent stem cells from other human cell lineages. The following chapters describe state-of-the-art differentiation and characterization of specific ectoderm, mesoderm and endoderm-derived lineages from human embryonic stem cells, emphasizing how these can be used to study human developmental mechanisms. A further chapter discusses genetic manipulation of human ES cells. The concluding section covers therapeutic applications of human ES cells, as well as addressing the ethical and legal issues that this research have raised.


Patient-Specific Stem Cells

Patient-Specific Stem Cells

Author: Deepak A. Lamba

Publisher: CRC Press

Published: 2017-04-07

Total Pages: 415

ISBN-13: 1315402165

DOWNLOAD EBOOK

One of the biggest challenges faced in medical research had been to create accurate and relevant models of human disease. A number of good animal models have been developed to understand the pathophysiology. However, not all of them reflect the human disorder, a classic case being Usher’s syndrome where the mutant mice do not have the same visual and auditory defects that patients face. There are others which have been even more difficult to model due to the multi-factorial nature of the condition and due to lack of discovery of a single causative gene such as age-related macular degeneration or Alzheimer’s syndrome. Thus a more relevant and accurate system will allow us to make better predictions on relevant therapeutic approaches. The discovery of human pluripotent stem cells in 1998 followed by the technological advances to reprogram somatic cells to pluripotent-stem cell-like cells in 2006 has completely revolutionized the way we can now think about modelling human development and disease. This now coupled with genome editing technologies such as TALENS and CRISPRs have now set us up to develop in vitro models both 2D as well as 3D organoids, which can more precisely reflect the disease in the patients. These combinatorial technologies are already providing us with better tools and therapeutics in drug discovery or gene therapy. This book summarizes both the technological advances in the field of generation of patient specific lines as well as various gene editing approaches followed by its applicability in various systems. The book will serve as a reference for the current state of the field as it: -Provides a comprehensive overview of the status of the field of patients derived induced pluripotent stem cells. -Describes the use of cardiac cells as a main featured component within the book. -Examines drug toxicity analysis as a working example throughout the book.


Cell-Based Therapy for Degenerative Retinal Disease

Cell-Based Therapy for Degenerative Retinal Disease

Author: Marco A. Zarbin

Publisher: Springer

Published: 2019-03-01

Total Pages: 280

ISBN-13: 3030052222

DOWNLOAD EBOOK

This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of “de-risking” that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.


BIOENGINEERING APPROACHES FOR IMPROVED DIFFERENTIATION OF CULTURED RETINAL TISSUES FROM PLURIPOTENT STEM CELLS

BIOENGINEERING APPROACHES FOR IMPROVED DIFFERENTIATION OF CULTURED RETINAL TISSUES FROM PLURIPOTENT STEM CELLS

Author: Michael Phelan

Publisher:

Published: 2021

Total Pages: 237

ISBN-13:

DOWNLOAD EBOOK

Sight is the most powerful of all human senses. For the vast majority of people on Earth, the loss of that sense would be unimaginable. Without assistive technology, it would separate them from their ability to work, their ability to travel, and their ability to interact with their loved ones. And yet, this extraordinary process, carefully refined by billions of years of evolution, is threatened for millions of people all over the world from a wide array of diseases of the retina. Many of these diseases arise from malnutrition and infection and are being rapidly eradicated. However, many dozens more result from convoluted permutations of genetics, age, and diet that threaten blindness for millions more with little hope of treatment, even with the best of modern medicine. As our life expectancies extend and our population ages, these diseases will only become more prevalent. In humanity's ever-present pursuit of medicine and knowledge to improve our quality of life, cutting-edge treatments offer promise that one day soon, even these diseases may be eradicated. One key technology capable of treating these devastating illnesses, on the precipice of being translated to real-world clinical treatments, is pluripotent stem cell-derived therapies. Patient-specific pluripotent stem cells, meaning pluripotent stem cells sourced directly from the patient, have a wealth of applications ranging from drug identification to disease modeling to implantation and regeneration. This research has been developed and advanced remarkably in the approximately two decades since the early isolation of pluripotent stem cells. Naturally, this advancement has predominantly been focused on cell and molecular biology. However, this focus has left significant research questions to be answered from engineering perspectives across a wide latitude of sub-disciplines. This dissertation explores three independent avenues of engineering principles as they relate to improving 2D and 3D retinal tissues derived from pluripotent stem cells in materials, devices, and computation. The first aim explores how plant protein-based nanofibrous scaffolds can marry the advantages and minimize the disadvantages of synthetic and animal-derived scaffolds for the culture of 2D retinal pigment epithelium (RPE) constructs. The second aim describes the development and testing of a novel, perfusing rotating wall vessel (RWV) bioreactor to support culture of 3D retinal organoids. Finally, the third aim performs a meta-analysis of published RNA-Seq datasets to determine the precise mechanisms by which bioreactors support organoid growth and extrapolate how these conclusions can support future experiments.


Stem Cell Biology and Regenerative Medicine in Ophthalmology

Stem Cell Biology and Regenerative Medicine in Ophthalmology

Author: Stephen Tsang

Publisher: Springer Science & Business Media

Published: 2012-12-09

Total Pages: 196

ISBN-13: 146145493X

DOWNLOAD EBOOK

Patient specific and disease specific stem cell lines have already introduced groundbreaking advances into the research and practice of ophthalmology. This volume provides a comprehensive and engaging overview of the latest innovations in the field. Twelve chapters discuss the fastest growing areas in ophthalmological stem cell research, from disease modelling, drug screening and gene targeting to clinical genetics and regenerative treatments. Innovative results from stem cell research of the past decade are pointing the way toward practicable treatments for retinitis pigmentosa, age related macular degeneration, and Stargardt disease. What future directions will stem cell research take? Researchers, graduate students, and fellows alike will find food for thought in this insightful guide tapping into the collective knowledge of leaders in the field. Stem Cells in Ophthalmology is part of the Stem Cells in Regenerative Medicine series dedicated to discussing current challenges and future directions in stem cell research.


Cell-Based Therapy for Retinal Degenerative Disease

Cell-Based Therapy for Retinal Degenerative Disease

Author: R.P. Casaroli-Marano

Publisher: Karger Medical and Scientific Publishers

Published: 2014-04-22

Total Pages: 220

ISBN-13: 3318025852

DOWNLOAD EBOOK

In this volume, some of the leading authorities present their exploration of applications of stem cell therapy to the treatment of major causes of blindness, including degenerative diseases and glaucoma. The diagnostic approach to patients, general concepts of cell-based therapy, immunological considerations, approaches to cell delivery (including engineered scaffolds), combined cell and gene therapy, nanomedicine applications to cell therapy and regulatory issues pertaining to manufacture and production are all considered in detail. The book serves as an excellent introduction to a field that is now entering early-stage clinical trials and promises to operate at the leading edge of regenerative medicine. Retina specialists, general ophthalmologists as well as researchers will find here a wealth of information on the translational aspects of cell-based therapies. Further, business executives and students interested in understanding the potential applications of stem cell therapy to retinal degenerative disease and glaucoma will also find this book informative reading.